Company
OCON Medical
Our mission is to introduce an innovative, high-quality intrauterine drug-delivery technology to improve and impact women’s health and quality of life
Also known as OCON Therapeutics
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
OCON Therapeutics innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB® (IntraUterineBall) proprietary platform. The IUB® made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.
Funding snapshot
- Total raised
- $10MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $10M2024-06-24
Funding rounds
- Round, 2024
- $10M2024-06-24, Company stated
Products
- Hardware
- IUB BALLERINE
- Hardware
- IUB PRIMA
- Hardware
- IUB SEAD
Loading relationship preview